LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for ORIC Pharmaceuticals Inc. and Millions of Other Companies

Sign up for full access to ORIC Pharmaceuticals Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Strategic Partnerships ORIC Pharmaceuticals Inc. has established partnerships with leading companies like Johnson & Johnson, opening up potential collaboration opportunities for sales expansion into new markets and customer segments.

Funding and Investment The company has received significant funding and investments from reputable firms like Vivo Capital LLC and institutional investors, indicating strong growth potential and increased capacity for product development and market penetration.

Key Personnel Expansion Recent appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs demonstrates a focus on strengthening the leadership team, signaling readiness for potential sales growth strategies and enhanced market positioning.

Financial Health With revenue ranging between $10M - $50M and securing $125M in funding, ORIC Pharmaceuticals Inc. exhibits a solid financial standing, providing a favorable environment for sales expansion initiatives and investment in sales strategies.

Investor Confidence Notable investments from entities like Strsoh, Chinauniversalasset, and significant funding rounds underscore investor confidence in the company's prospects, implying favorable conditions for sales engagements and potential partnership opportunities.

Similar companies to ORIC Pharmaceuticals Inc.

✕

Access Insights for ORIC Pharmaceuticals Inc. and Millions of Other Companies

Sign up for full access to ORIC Pharmaceuticals Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

ORIC Pharmaceuticals Inc. Tech Stack

ORIC Pharmaceuticals Inc. uses 8 technology products and services including Akamai, jQuery CDN, Backbone.js, and more. Explore ORIC Pharmaceuticals Inc.'s tech stack below.

  • Akamai
    Content Delivery Network
  • jQuery CDN
    Content Delivery Network
  • Backbone.js
    Javascript Frameworks
  • Exhibit
    Javascript Graphics
  • Modernizr
    Javascript Libraries
  • Windows Server
    Operating Systems
  • Yoast SEO
    Search Engines
  • Expensify
    Travel And Expense Management

Media & News

ORIC Pharmaceuticals Inc.'s Email Address Formats

ORIC Pharmaceuticals Inc. uses at least 1 format(s):
ORIC Pharmaceuticals Inc. Email FormatsExamplePercentage
First.Last@oricpharma.comJohn.Doe@oricpharma.com
95%
Last@oricpharma.comDoe@oricpharma.com
3%
First.Middle@oricpharma.comJohn.Michael@oricpharma.com
1%
Fir.Last@oricpharma.comJoh.Doe@oricpharma.com
1%

Frequently Asked Questions

Where is ORIC Pharmaceuticals Inc.'s headquarters located?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc.'s main headquarters is located at 240 E Grand Ave 2nd Floor South San Francisco, California 94080 US. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is ORIC Pharmaceuticals Inc.'s phone number?

Minus sign iconPlus sign icon You can contact ORIC Pharmaceuticals Inc.'s main corporate office by phone at
✕

Access Insights for ORIC Pharmaceuticals Inc. and Millions of Other Companies

Sign up for full access to ORIC Pharmaceuticals Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-388-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ORIC Pharmaceuticals Inc.'s stock symbol?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc. is a publicly traded company; the company's stock symbol is ORIC.

What is ORIC Pharmaceuticals Inc.'s official website and social media links?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc.'s official website is oricpharma.com and has social profiles on LinkedIn.

How much revenue does ORIC Pharmaceuticals Inc. generate?

Minus sign iconPlus sign icon As of August 2024, ORIC Pharmaceuticals Inc.'s annual revenue reached $15M.

What is ORIC Pharmaceuticals Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ORIC Pharmaceuticals Inc. have currently?

Minus sign iconPlus sign iconAs of August 2024, ORIC Pharmaceuticals Inc. has approximately 111 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: D. P.Chief Scientific Officer: L. F.Chief Medical Officer: P. M.. Explore ORIC Pharmaceuticals Inc.'s employee directory with LeadIQ.

What industry does ORIC Pharmaceuticals Inc. belong to?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc. operates in the Biotechnology Research industry.

What technology does ORIC Pharmaceuticals Inc. use?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc.'s tech stack includes AkamaijQuery CDNBackbone.jsExhibitModernizrWindows ServerYoast SEOExpensify.

What is ORIC Pharmaceuticals Inc.'s email format?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc.'s email format typically follows the pattern of . Find more ORIC Pharmaceuticals Inc. email formats with LeadIQ.

How much funding has ORIC Pharmaceuticals Inc. raised to date?

Minus sign iconPlus sign icon As of August 2024, ORIC Pharmaceuticals Inc. has raised $125M in funding. The last funding round occurred on Jan 30, 2024 for $125M.

When was ORIC Pharmaceuticals Inc. founded?

Minus sign iconPlus sign iconORIC Pharmaceuticals Inc. was founded in 2014.
ORIC Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (3) ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens, being developed for multiple myeloma. Beyond these three product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.

✕

Access Insights for ORIC Pharmaceuticals Inc. and Millions of Other Companies

Sign up for full access to ORIC Pharmaceuticals Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
240 E Grand Ave 2nd Floor South San Francisco, California 94080 US
Phone number
✕

Access Insights for ORIC Pharmaceuticals Inc. and Millions of Other Companies

Sign up for full access to ORIC Pharmaceuticals Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-388-****
Website
oricpharma.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ORIC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $125M

    ORIC Pharmaceuticals Inc. has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $125M.

  • $10M$50M

    ORIC Pharmaceuticals Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $125M

    ORIC Pharmaceuticals Inc. has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $125M.

  • $10M$50M

    ORIC Pharmaceuticals Inc.'s revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for ORIC Pharmaceuticals Inc. and Millions of Other Companies

Sign up for full access to ORIC Pharmaceuticals Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.